Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer

Checkpoint inhibitor-related pneumonitis (CIP) is one of the most important immune checkpoint inhibitors side effects, and it is rare but fatal. Identifying patients at risk of refractory CIP before the start of CIP therapy is important for controlling CIP. We retrospectively analyzed the clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Peixin, Huang, Wei, He, Xinyan, Lv, Fengquan, Cui, Yanhai, Du, Shasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889196/
https://www.ncbi.nlm.nih.gov/pubmed/36637978
http://dx.doi.org/10.1097/CJI.0000000000000451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889196/
https://www.ncbi.nlm.nih.gov/pubmed/36637978
http://dx.doi.org/10.1097/CJI.0000000000000451

Ejemplares similares